Insiders are Bearish on These Healthcare Stocks

Wall St. Watchdog reveals information about insiders who are bearish on these stocks in the Healthcare sector for the week ending November 11th, 2011.

  • Stephen J Long who is VP, Gen Counsel and Secretary at CR Bard Inc. (NYSE:BCR), sold 14,750 shares on Nov 08 at $88.58 per share for a total value of $1,306,514. The shares recently traded at $87.94, down $1.39, or 1.56% since the insider sale. About the company: C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices. The Company sells a broad range of products worldwide to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. Bard markets vascular, urological, oncological, and surgical specialties products. Get the most recent company news and stock data here >>
  • Elisha W Finney who is SVP, Finance and CFO at Varian Medical Systems Inc. (NYSE:VAR), sold 5,000 shares on Nov 07 at $58.00 per share for a total value of $290,000. The shares recently traded at $57.05, down $1.13, or 1.94% since the insider sale. About the company: Varian Medical Systems, Inc. designs, manufactures, sells, and services equipment and software products for treating cancer with radiotherapy, stereotactic radiosurgery and brachytherapy. The Company also supplies products that include x-ray tubes, linear accelerators, digital image detectors, image processing software and image detection products. Get the most recent company news and stock data here >>
  • Anna Richo who is SVP & CCO at Amgen Inc. (NASDAQ:AMGN), sold 1,500 shares on Nov 08 at $58.07 per share for a total value of $87,105. The shares recently traded at $57.33, down $0.67, or 1.16% since the insider sale. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation. Get the most recent company news and stock data here >>
  • Kevin W Sharer who is Chairman of the Board and CEO at Amgen Inc. (NASDAQ:AMGN), sold 52,500 shares on Nov 08 at $58.22 per share for a total value of $3,056,608. The shares recently traded at $57.33, down $0.67, or 1.16% since the insider sale. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation. Get the most recent company news and stock data here >>
  • Fabrizio Bonanni who is EVP, Operations at Amgen Inc. (NASDAQ:AMGN), sold 10,000 shares on Nov 08 at $58.12 per share for a total value of $581,233. The shares recently traded at $57.33, down $0.67, or 1.16% since the insider sale. About the company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation. Get the most recent company news and stock data here >>
  • Bruce J Goodman who is Sr. VP at Humana Inc. (NYSE:HUM), sold 19,003 shares on Nov 08 at $86.97 per share for a total value of $1,652,691. The shares recently traded at $87.72, up $0.57, or 0.65% since the insider sale. About the company: Humana Inc. is a managed health care company with medical members located in the United States and Puerto Rico. The Company offers coordinated health care through health maintenance organizations, preferred provider organizations, point-of-service plans, and administrative services products. Humana offers its products to employer groups, government-sponsored plans, and individuals. Get the most recent company news and stock data here >>
  • Ronda E Stryker who is Director at Stryker Corp. (NYSE:SYK), sold 9,000 shares on Nov 09 at $48.34 per share for a total value of $435,055. The shares recently traded at $48.94, up $1.44, or 3.03% since the insider sale. About the company: Stryker Corporation develops, manufactures, and markets specialty surgical and medical products. The Company’s products include implants, biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Get the most recent company news and stock data here >>
  • Bryce D Carmine who is EVP and Pres, Lilly Bio-Meds at Eli Lilly & Co. (NYSE:LLY), sold 5,700 shares on Nov 11 at $37.55 per share for a total value of $214,035. The shares recently traded at $37.65, down $0.2, or 0.53% since the insider sale. About the company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from publicly available SEC filings. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet